Credit: Tel Aviv University
Groundbreaking research from Tel Aviv University may lead to a significant breakthrough in the battle against deadly brain cancer. To begin with, the researchers identified a failure in the brain s immune system, leading to the amplification of cell division and spread of Glioblastoma cancer cells. The failure results partially from the secretion of a protein called P-Selectin (SELP), which, when bound to its receptor on the brain immune cells, alters their function so that instead of inhibiting the spread of cancer cells, they do the opposite, enabling them to proliferate and penetrate brain tissues.
At the next stage of the study, the researchers were able to inhibit the secretion of the SELP protein, thereby neutralizing the failure in the immune system, restoring its normal activity, and blocking the spread of this incurable cancer. The international research team was led by Prof. Ronit Satchi-Fainaro, Director of the Cancer Biology Research Center a
TAU Breakthrough: Activating Brain s Immune System Against Deadly Cancer Glioblastoma Prevents Spreading | The Jewish Press - JewishPress com | Jewish Press News Desk | 29 Nisan 5781 – April 11, 2021
jewishpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from jewishpress.com Daily Mail and Mail on Sunday newspapers.
Alpha Epsilon Pi Launches The Kotel Project to Raise Money For Jewish Causes and Allow For Connections to Jerusalem
jns.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from jns.org Daily Mail and Mail on Sunday newspapers.
E-Mail
To observe how a tiny ball of identical cells on its way to becoming a mammalian embryo first attaches to an awaiting uterine wall and then develops into nervous system, heart, stomach and limbs: This has been a highly-sought grail in the field of embryonic development for nearly 100 years. Prof. Jacob Hanna of the Weizmann Institute of Science and his group have now accomplished this feat. The method they created for growing mouse embryos outside the womb during the initial stages after embryo implantation will give researchers an unprecedented tool for understanding the development program encoded in the genes, and it may provide detailed insight into birth and developmental defects as well as those involved in embryo implantation. The results of this research were published in
Beryl Chernov Named National Executive Director OF THE ISRAEL CANCER RESEARCH FUND (ICRF)
Beryl Chernov Named National Executive Director OF THE ISRAEL CANCER RESEARCH FUND (ICRF)
Chernov has held the position of Executive Director of Park Avenue Synagogue in New York City for 19 years.
Spread the word.
(February 17, 2021, JNS Wire) The Israel Cancer Research Fund (ICRF) is pleased to announce the appointment of Beryl Chernov to National Executive Director, effective July 1, 2021. He will succeed Mark Israel, MD, who will be retiring after three years of exemplary service with the organization.
Chernov will be joining ICRF from the Park Avenue Synagogue, the largest Conservative synagogue in New York City, where he served as Executive Director for 19 years. Overseeing an annual budget of $19 million, he was responsible for development, as well as membership cultivation, technology, and operations.